Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
Next >
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
July 29, 2024
Tickers
BIIB
ESALY
Tags
ESALY
Market News
BIIB
From
Motley Fool
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Stories That Matter
ESALF
Top Stories
From
Benzinga
This Is Massive News for Eli Lilly Investors
June 29, 2024
Tickers
BIIB
ESALY
LLY
NVO
Tags
BIIB
Recent Press Releases
ESALY
From
Motley Fool
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
April 24, 2024
Tickers
BIIB
ESALY
NEWS
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
March 22, 2024
Tickers
BIIB
ESALF
ESALY
NEWS
Tags
Stories That Matter
ESALF
Movers
From
Benzinga
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
March 08, 2024
Tickers
BIIB
ESALY
LLY
NEWS
Tags
Market News
LLY
Benzinga
From
Benzinga
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
February 14, 2024
Tickers
BIIB
ESALY
NEWS
NVS
Tags
Health Care
BIIB
Biotech
From
Benzinga
Why Is Biogen Stock Trading Lower On Tuesday?
February 13, 2024
Tickers
BIIB
ESALY
NEWS
Tags
Market News
Benzinga
Large Cap
From
Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
Tickers
BIIB
DGX
ESALY
LH
Tags
Market News
Benzinga
LH
From
Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
Tickers
ESALF
ESALY
MRK
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
Small Cap
Biotech
ESAIY
From
Benzinga
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
November 08, 2023
Tickers
BIIB
ESALY
Tags
General
Briefs
why it's moving
From
Benzinga
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
October 13, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Government
General
Regulations
From
Benzinga
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Tickers
BIIB
DGX
ESALY
LH
Tags
RHHBY
General
News
From
Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
General
Briefs
News
From
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Tickers
AA
AAPL
AMZN
BIIB
Tags
Market News
Penny Stocks
AAPL
From
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
September 25, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
General
Health Care
From
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Tickers
ESALF
ESALY
MRK
Tags
ESALF
News
Briefs
From
Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
Tickers
ESALF
ESALY
MRK
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Tickers
BIIB
ESALY
RETA
Tags
Market News
ESALY
Recent Press Releases
From
Motley Fool
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
July 07, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Analyst Color
Expert Ideas
From
Benzinga
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
June 14, 2023
Tickers
BIIB
ESALY
Tags
Market News
Benzinga
Biotech
From
Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
June 13, 2023
Tickers
AAPL
ATVI
BEP
BIIB
Tags
GM
TM
PTEN
From
Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Top Stories
Markets
From
Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Large Cap
Biotech
BIIB
From
Benzinga
Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
June 12, 2023
Tickers
BIIB
ESALY
ILMN
KDNY
Tags
News
KDNY
ESALY
From
Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Health Care
BIIB
Biotech
From
Benzinga
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
June 08, 2023
Tickers
AMZN
BLK
DIS
EADSY
Tags
Markets
Top Stories
GOOGL
From
Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
BIIB
Health Care
From
Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
June 01, 2023
Tickers
ESALY
IEF
MDT
MRK
Tags
ESALY
News
Jason Snipe
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.